45 results
8-K
EX-4.1
RCEL
AVITA Medical Inc
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
Certificate:
(a)Voting Rights. This Warrant Certificate does not carry any voting rights at stockholder meetings of the Company unless and until
8-K
EX-10.2
l9nu22bl9
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
424B5
vhsej2 z7lfsp
18 Oct 23
Prospectus supplement for primary offering
9:04am
424B2
87ewnyvf72 n5
25 Apr 23
Prospectus for primary offering
5:28pm
10-KT
EX-10.25
o701yj4obrhjsgt
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
ona78u15qnz
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
EX-10.28
rgyo d4j5q
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
EX-10.24
0du9o4
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
EX-10.26
wbdotjtniapsmq 4jg
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
EX-10.27
cfksoblmnfpo9w
28 Feb 22
Annual report (with FYE transition)
4:11pm